Artiva Biotherapeutics, Inc. ($ARTV)
Filing Information
| Accession Number | 0001193125-26-389512 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 11, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
160,000
Total Value
$0.00
P&L
+inf% (+$1,425,600.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Tech Operations Officer | Common Stock | โ | Sep 9, 2026 | Grant/Award | 40,000 | $0.00 | $0.00 | 323,084 | Direct | โ | View Details | |
Chief Tech Operations Officer | Employee Stock Option (Right to Buy) | Derivative | Sep 9, 2026 | Grant/Award | 120,000 | $0.00 | $0.00 | 120,000 | Direct | โ | View Details |